BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31181289)

  • 1. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
    Collin F; Maxwell A
    J Mol Biol; 2019 Aug; 431(18):3400-3426. PubMed ID: 31181289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of full length and truncated microcin B17 analogues as DNA gyrase poisons.
    Thompson RE; Collin F; Maxwell A; Jolliffe KA; Payne RJ
    Org Biomol Chem; 2014 Mar; 12(10):1570-8. PubMed ID: 24448886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.
    Yorgey P; Lee J; Kördel J; Vivas E; Warner P; Jebaratnam D; Kolter R
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4519-23. PubMed ID: 8183941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo processing and antibiotic activity of microcin B17 analogs with varying ring content and altered bisheterocyclic sites.
    Sinha Roy R; Kelleher NL; Milne JC; Walsh CT
    Chem Biol; 1999 May; 6(5):305-18. PubMed ID: 10322125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites.
    Zamble DB; Miller DA; Heddle JG; Maxwell A; Walsh CT; Hollfelder F
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7712-7. PubMed ID: 11427730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of the bacterial toxin microcin B17. Insight into the cleavage-religation reaction of DNA gyrase.
    Pierrat OA; Maxwell A
    J Biol Chem; 2003 Sep; 278(37):35016-23. PubMed ID: 12829716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and regioselectivity of peptide-to-heterocycle conversions by microcin B17 synthetase.
    Belshaw PJ; Roy RS; Kelleher NL; Walsh CT
    Chem Biol; 1998 Jul; 5(7):373-84. PubMed ID: 9662507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase.
    Li YM; Milne JC; Madison LL; Kolter R; Walsh CT
    Science; 1996 Nov; 274(5290):1188-93. PubMed ID: 8895467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of the bacterial toxin, microcin B17, on DNA gyrase.
    Parks WM; Bottrill AR; Pierrat OA; Durrant MC; Maxwell A
    Biochimie; 2007 Apr; 89(4):500-7. PubMed ID: 17276574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragments of the bacterial toxin microcin B17 as gyrase poisons.
    Collin F; Thompson RE; Jolliffe KA; Payne RJ; Maxwell A
    PLoS One; 2013; 8(4):e61459. PubMed ID: 23593482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase.
    Vizán JL; Hernández-Chico C; del Castillo I; Moreno F
    EMBO J; 1991 Feb; 10(2):467-76. PubMed ID: 1846808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase.
    Pierrat OA; Maxwell A
    Biochemistry; 2005 Mar; 44(11):4204-15. PubMed ID: 15766248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microcins--peptide antibiotics of enterobacteria: genetic control of the synthesis, structure, and mechanism of action].
    Khmel' IA
    Genetika; 1999 Jan; 35(1):5-16. PubMed ID: 10330606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the microcin B17 propeptide in substrate recognition: solution structure and mutational analysis of McbA1-26.
    Roy RS; Kim S; Baleja JD; Walsh CT
    Chem Biol; 1998 Apr; 5(4):217-28. PubMed ID: 9545435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase.
    Yorgey P; Davagnino J; Kolter R
    Mol Microbiol; 1993 Aug; 9(4):897-905. PubMed ID: 8231817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Potential and Synergetic Effects of Microcins against Multidrug-Resistant
    Telhig S; Ben Said L; Torres C; Rebuffat S; Zirah S; Fliss I
    Microbiol Spectr; 2022 Jun; 10(3):e0275221. PubMed ID: 35543514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressed protein ligation to probe regiospecificity of heterocyclization in the peptide antibiotic microcin B17.
    Roy RS; Allen O; Walsh CT
    Chem Biol; 1999 Nov; 6(11):789-99. PubMed ID: 10574779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leader peptide is essential for the post-translational modification of the DNA-gyrase inhibitor microcin B17.
    Madison LL; Vivas EI; Li YM; Walsh CT; Kolter R
    Mol Microbiol; 1997 Jan; 23(1):161-8. PubMed ID: 9004229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase inhibitor microcin B17: distance dependence from propeptide and tolerance for substitution in a GSCG cyclizable sequence.
    Sinha Roy R; Belshaw PJ; Walsh CT
    Biochemistry; 1998 Mar; 37(12):4125-36. PubMed ID: 9521734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.